Celltrion USA announces availability of adalimumab-aaty with 85% discount
In a bold move to reshape the pharmaceutical landscape, Celltrion USA has announced the availability of its high-concentration, citrate-free biosimilar adalimumab-aaty, under the brand name ... Read More